OBB Newsletter

  • Enter your e-mail address below to subscribe to the Orange Book Blog newsletter. If a new post is added during the day, you'll receive it by e-mail the next morning.

Enter your email address:

Delivered by FeedBurner




  • Orange Book Blog is published for informational purposes only; it contains no legal advice whatsoever. Publication of Orange Book Blog does not create an attorney-client relationship. Orange Book Blog is Aaron Barkoff's personal website and it is intended for other attorneys. Orange Book Blog is not edited by McAndrews, Held & Malloy, Ltd. ("MHM") or its clients. No part of Orange Book Blog--whether information, commentary, or other--may be attributed to MHM or its clients. MHM represents many companies in the pharmaceutical and biotechnology industries, and therefore Orange Book Blog may occasionally report on news that relates to MHM clients. Orange Book Blog will always strive to be unbiased. All information on Orange Book Blog should be double-checked for its accuracy and current applicability. -- © Aaron F. Barkoff 2006-2017

« Sanofi and BMS Prevail Over Apotex in Plavix Appeal | Main | Supreme Court Denies Cert Petition in Lovenox Case »

February 24, 2009



Quite a time since last post. happy to see the activity.
Best of luck!


Thanks for sticking around. I've been very busy with billable work and haven't been able to keep up with this as much as I would like.

Pacific Reporter

Glad to see you're posting again.
I think the only reason Teva wants the 30-month stay to expire is so it can threaten to launch "at-risk" (i.e. while litigation is still pending). That way it will have more leverage when negotiating a reverse payment settlement with Lilly. I expect Lilly will settle with Teva in a few months, and that Teva will get a big payout to go away.

The comments to this entry are closed.